<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>This Common Heart Attack Drug May Not Help Most Heart Attack Patients</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2025/09/03/this-common-heart-attack-drug-may-not-help-most-heart-attack-patients.aspx</link><description>For decades, beta-blockers have been prescribed after heart attacks to protect the heart and lower the chance of another episode. But new international trial data suggests this long-standing practice may not help most patients &amp;mdash; and may even add</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>